Drug Manufacturers - Specialty & Generic · Healthcare
General Counsel
General Counsel
Emergent BioSolutions Inc. (EBS)Equibles does not estimate personal net worth.
Get an email with a short summary when Emergent BioSolutions Inc. publishes a filing, an earnings call transcript or a press release.
Get EBS alertsJessica Perl is recorded as General Counsel at Emergent BioSolutions Inc. (EBS). The newest filing on record that lists Jessica Perl as General Counsel at Emergent BioSolutions Inc. (EBS) is dated March 20, 2026. Emergent BioSolutions Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Emergent BioSolutions Inc. includes Daniel J. Abdun-Nabi (CEO, COO and Board Member), Joseph C. Papa (CEO and Board Member), Joseph Papa (CEO and Board Member) and 7 others.
Start not stated–present
Last confirmed March 20, 2026
Drug Manufacturers - Specialty & Generic · Healthcare
General Counsel
No call appearances or filed executive changes recorded yet.